Frank D. Morrow, Ph.D., FACN has been appointed chief operating officer of LabConnect. Dr. Morrow is a veteran of the central lab business having served as founding executive, president and chief scientific officer at Quintiles Laboratories Worldwide. He was responsible for the division’s growth from inception to $120M in revenue, 1,000 employees, and five central lab facilities worldwide, for more than 10 years. After Quintiles, he served as vice president, Worldwide Operations at Quest Diagnostics Clinical Trials.

“We’re pleased to have one of the industry’s most experienced executives join our team,” noted Eric Hayashi, LabConnect president & chief executive officer. “Frank has the right combination of operational and scientific expertise and the passion to surprise and delight our clients.”

“LabConnect represents the next generation of central labs,” said Dr. Morrow. “Biopharmaceutical sponsors’ increasingly complex testing requirements — both analytically and geographically — necessitate a better operating model for central laboratory services. LabConnect has integrated several of the largest and most experienced global laboratories under a highly advanced information systems platform and has the ability to expertly coordinate multiple specialty labs.”

Sign up today for Contracting & Outsourcing 2009!
contractpharma.com/2009conference